A measurable fingerprint of very long and healthy life
In the blood of those who have crossed a century of living, Boston University researchers have found a quiet chemical testament to exceptional survival — a pattern of elevated bile acids and preserved steroids that distinguishes centenarians not merely from their peers, but from the ordinary arc of human aging. Drawing on the New England Centenarian Study, scientists measured nearly fifteen hundred molecules across three generations of participants, uncovering a metabolic fingerprint that correlates with lower mortality and, in some individuals, a biological age younger than the calendar would suggest. The discovery does not yet explain why some people age more slowly, but it offers the first legible sentences of a language written in blood chemistry — one that may eventually help medicine speak back.
- The central tension is one of correlation versus causation: the metabolic fingerprint is real and reproducible, but researchers cannot yet say whether it drives longevity or simply accompanies it.
- The disruption to conventional thinking is significant — luck and genetics alone no longer seem sufficient to explain who reaches one hundred, as measurable blood chemistry now enters the equation.
- To navigate toward answers, the team cross-validated their findings against four independent metabolomics datasets and built a machine-learning 'metabolomic clock' capable of estimating biological age from blood alone.
- The study's cross-sectional design and its focus on a largely New England population leave critical gaps that larger, more diverse longitudinal studies must now fill.
- The trajectory points toward clinical application — these markers could one day serve as biomarkers for biological aging and as targets for therapies designed to extend not just lifespan, but healthy, active years.
Somewhere in the blood of people who live past one hundred, there is a chemical signature that hints at why they made it that far. Researchers at Boston University have begun to read it. Working through the New England Centenarian Study, a team led by Thomas Perls examined blood samples from 213 participants — seventy centenarians, their adult children, and age-matched controls — measuring roughly 1,495 distinct molecules per sample using a technique called untargeted metabolomics. The scale allowed them to see patterns invisible to smaller investigations.
What emerged was striking: centenarians carried unusually high levels of certain primary and secondary bile acids, compounds the liver produces to aid digestion and metabolism, and maintained elevated steroids at ages when these typically decline. When the team checked their findings against four additional metabolomics datasets, the same signatures appeared consistently. It was not noise. It was real.
The researchers then asked which metabolites actually predicted survival after blood was drawn. A machine-learning model — a 'metabolomic clock' — could estimate biological age from blood chemistry alone, and those who were biologically younger than their years tended to live longer. Corresponding author Stefano Monti described the centenarian blood profile as a measurable fingerprint of long and healthy life, pointing toward pathways involving bile acids, NAD metabolism, gut bacteria, oxidative stress, and hormones as worthy of deeper investigation.
Monti was careful, however, about what the study cannot yet claim. Because it captures a single moment rather than tracking people forward, it cannot prove these patterns cause longevity — only that they travel alongside it. Validation in larger, more diverse populations remains essential. Still, the door is open: these markers could one day help clinicians estimate biological age, flag individuals at risk of accelerated decline, and measure responses to lifestyle changes or new therapies. The translation from chemical insight to human benefit lies ahead, but the map has begun to take shape.
Somewhere in the blood of people who live past one hundred, there is a chemical signature that tells a story about why they made it that far. Researchers at Boston University have now begun to read that story. They found that centenarians carry distinctive patterns of molecules in their bloodstream—particularly elevated bile acids and preserved steroids—that set them apart not just from people their age, but from the normal trajectory of aging itself. These patterns appear to correlate with lower mortality risk, suggesting that the body's chemistry, not just luck or genetics alone, plays a measurable role in exceptional longevity.
The discovery emerged from the New England Centenarian Study, one of North America's most comprehensive investigations into people who have lived one hundred years or more. The research team, led by Thomas Perls, examined blood samples from 213 participants: seventy centenarians, their adult children, and age-matched control subjects. Using a technique called untargeted metabolomics, the scientists measured approximately 1,495 distinct small molecules present in each blood sample. The scale of this work—tracking nearly fifteen hundred chemical compounds across three generations and multiple age groups—allowed them to identify patterns that would have been invisible in smaller studies.
What emerged was striking. Centenarians showed unusually high levels of certain primary and secondary bile acids, compounds produced by the liver that aid in digestion and metabolism. They also maintained elevated levels of specific steroids at ages when these typically decline. When the researchers compared their findings against four additional metabolomics datasets from other studies, these same chemical signatures appeared consistently. The pattern held. It was not noise or artifact. It was real.
The team then asked a crucial question: which of these metabolites actually predicted how long people lived after their blood was drawn? This survival analysis revealed that certain metabolic patterns were indeed associated with longer life spans. The researchers even built a machine-learning model—what they called a "metabolomic clock"—that could estimate a person's biological age based solely on their blood chemistry. Some people, it turned out, were biologically younger than their chronological age suggested. Those individuals tended to live longer.
Stefano Monti, the study's corresponding author, framed the implications carefully. The blood chemistry of centenarians represents, in his words, a measurable fingerprint of very long and healthy life. If scientists can understand what that fingerprint means—which biological pathways it reflects, which processes it protects—they might eventually identify ways to help other people age more slowly. The pathways worth investigating include those involving bile acids, NAD metabolism, gut bacteria, oxidative stress, and certain hormones.
But Monti was also precise about what the study cannot yet claim. The research is cross-sectional, meaning it captures a moment in time rather than tracking people forward. The team cannot yet prove that these metabolic patterns cause longevity, only that they correlate with it. The findings need validation in larger, more diverse populations. What works in a study of New England centenarians may not hold universally.
Still, the door is now open. These metabolic markers could eventually become clinical biomarkers—measurable signs that doctors could track to estimate biological age, identify people at higher or lower risk of age-related decline, and monitor how well someone responds to lifestyle changes or new medications. The ultimate goal is to translate these chemical insights into interventions that help people not just live longer, but live longer while remaining healthy and active. That translation, however, remains ahead.
Citações Notáveis
Our study points to measurable chemical fingerprints in the blood that are associated with living a very long and healthy life. If we can understand those fingerprints, we may identify biological pathways that could contribute to protecting people from age-related decline.— Stefano Monti, PhD, professor of medicine at Boston University
The study's cross-sectional design means we cannot yet determine cause and effect, and these findings need validation in larger, diverse populations. Ultimately, our goal is to translate these insights into tests and safe interventions that help people stay healthier and more active for longer.— Stefano Monti, PhD
A Conversa do Hearth Outra perspectiva sobre a história
Why does the blood chemistry of someone who lives to one hundred look so different from someone who lives to eighty-five?
That's the question the researchers are still working to answer. What they found is that centenarians have higher levels of bile acids and preserved steroids—but whether those chemicals are causing the longevity or simply reflecting something else the body is doing right, we don't yet know.
So these are just markers, not mechanisms?
Exactly. They're like smoke signals. You can see them clearly, measure them precisely, but the fire underneath—the actual biological process keeping someone alive longer—that's what needs more investigation.
The study looked at nearly fifteen hundred molecules. How do you even know which ones matter?
They compared their findings against four other studies to see which patterns showed up consistently. That filtering process helps separate the meaningful signals from the noise. But it's still early. They're pointing at pathways worth studying, not claiming they've found the answer.
Could this eventually become a test a doctor could order?
That's the hope. Imagine a blood test that tells you whether you're aging faster or slower than your chronological age suggests. That could change how we think about prevention and intervention. But first it needs to work across different populations, different geographies, different genetic backgrounds.
What about the people in the study—the centenarians themselves? What made them special?
The study doesn't really tell us that. It tells us what their blood looks like. Whether they exercised, what they ate, how they managed stress—those details aren't in the chemistry. The metabolites are a window, but not the whole view.